70
Participants
Start Date
February 7, 2023
Primary Completion Date
April 11, 2025
Study Completion Date
April 11, 2025
Isavuconazole
This is a single arm study, all enrolled participants will receive the study intervention.
Peking University People's Hospital, Beijing
Huashan Hospital, Fudan University, Shanghai
Jiading Central Hospital, Shanghai
The First Affiliated Hospital of USTC, Anhui Province Hospital, Hefei
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Liaocheng people's Hospital, Liaocheng
Zibo Central Hospital, Zibo
Institute of Hematology, Chinese Academy of Medical Sciences, Tianjin
The First Affiliated Hospital Zhejiang University, Hangzhou
Henan provincial people's hospital, Zhengzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Guangzhou First People's Hospital, Guangzhou
ZhuJiang Hospital of Southern Medical University, Guangzhou
Jieyang People's Hospital, Jieyang
Lead Sponsor
Pfizer
INDUSTRY